Covaxin: Phase 3 Human Trial for Bharat Biotech's COVID-19 Vaccine Starts at SRM Medical College Hospital and Research Centre in Chennai
In a statement issued here, the SRM Medical College Hospital said the vaccine in the third phase will be tested on about 1,000-1,500 volunteers. During the first phase, the vaccine was tested on 30 volunteers, and in the second phase, on over 150 persons and their health is being monitored, it added.
Chennai, December 7: The SRM Medical College Hospital and Research Centre here on Monday announced the launch of the third phase of human trials for Covaxin - a vaccine for Covid-19 developed by Bharat Biotech.
In a statement issued here, the SRM Medical College Hospital said the vaccine in the third phase will be tested on about 1,000-1,500 volunteers. COVID-19 Vaccine Price: Russia Sets Maximum Wholesale Rate For Sputnik V at $26 For 2 Doses.
During the first phase, the vaccine was tested on 30 volunteers, and in the second phase, on over 150 persons and their health is being monitored, it added.
(The above story first appeared on LatestLY on Dec 07, 2020 07:12 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).